# FDA Inspection 1061621 - TissueTech, Inc. - July 26, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/tissuetech-inc/081fa57a-6554-45f0-90f3-a5b5bcf06091
Source feed: FDA_Inspections

> FDA Inspection 1061621 for TissueTech, Inc. on July 26, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061621
- Company Name: TissueTech, Inc.
- Inspection Date: 2018-07-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 989324 - 2016-05-24](https://www.globalkeysolutions.net/records/fda_inspections/tissuetech-inc/3316fbdc-6983-4e18-9a8f-b9177b724d99)
- [FDA Inspection 756664 - 2011-12-09](https://www.globalkeysolutions.net/records/fda_inspections/tissuetech-inc/d926f1aa-24b0-4653-928e-4b584490daeb)

Company: https://www.globalkeysolutions.net/companies/tissuetech-inc/a5d3c5e5-1dec-4317-a898-1adbe9528d43

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d